Prevalence, virulence factors and antifungal susceptibility of Candida spp. isolated from bloodstream infections in a tertiary care hospital in Brazil

Mycoses. 2018 Jan;61(1):11-21. doi: 10.1111/myc.12695. Epub 2017 Sep 22.

Abstract

Candida spp. are responsible for 80% of all systemic fungal infections and are associated with high mortality rates. This study characterised 79 bloodstream isolates of C. albicans, C. glabrata, C. orthopsilosis, C. parapsilosis and C. tropicalis from patients in a Brazilian hospital. The susceptibility to amphotericin B, caspofungin, fluconazole and voriconazole was determined; virulence factor production was assessed based on haemolysin, phospholipase and proteinase activities, and the patients' clinical characteristics were analysed. C. albicans was the predominant species (44%), followed by C. glabrata (19%), C. tropicalis (19%), C. parapsilosis (14%) and C. orthopsilosis (4%). The candidemia incidence was 1.52 per 1000 admissions, and the crude mortality rate was 52%. One C. albicans isolate was resistant to fluconazole and voriconazole. Moreover, 20.2%, 2.5% and 3.8% of the isolates exhibited dose-dependent susceptibility to fluconazole, voriconazole and caspofungin, respectively. In conclusion, although the C. glabrata incidence was higher than that usually described in Brazil, its increase was previously observed in studies conducted worldwide. Furthermore, the azole resistance of the C. albicans isolate could be due to previous exposure to these antifungals. These results highlight the importance of epidemiological studies and will facilitate an improved understanding of candidemia in the studied hospital.

Keywords: Candida spp.; antifungal susceptibility; candidemia; virulence factors.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antifungal Agents / pharmacology*
  • Brazil / epidemiology
  • Candida / classification*
  • Candida / drug effects
  • Candida / isolation & purification
  • Candida / pathogenicity
  • Candida glabrata / drug effects
  • Candida glabrata / isolation & purification
  • Candida glabrata / pathogenicity
  • Candidemia / epidemiology
  • Candidemia / microbiology*
  • Candidemia / mortality
  • Child
  • Child, Preschool
  • Drug Resistance, Fungal
  • Female
  • Humans
  • Incidence
  • Infant
  • Infant, Newborn
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Prevalence
  • Tertiary Care Centers
  • Virulence Factors
  • Young Adult

Substances

  • Antifungal Agents
  • Virulence Factors